Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
NCT02245503
·
clinicaltrials.gov ↗
COMPLETED
Status
7391
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
Tamsulosin
Sponsor
Boehringer Ingelheim